Ver mas grande
ELISA Kit for Carboxymethyl Lysine (CML)
CC-CEB977Ge
Producto nuevo
48T, 96T, 96T×5, 96T×10, 96T×100
Comprando este producto generará 8 Biopuntos. Su cesta contiene un total 8 Biopuntos puede ser convertido en un Biobonos Descuento 32.00EUR.
Hoja técnica
| Size | 96T |
| Storage Conditions | -20°C |
| Shipping Conditions | Entre 4°C y 8°C |
| Applications | Enzyme-linked immunosorbent assay for Antigen Detection. |
| Detection Range | 61.7-5,000ng/mL |
| Sensitivity | The minimum detectable dose of this kit is typically less than 25.9ng/mL |
| Research Area | Metabolic pathway |
| Organism species | Pan-species (General) |
| Alternative Names | N(6)-Carboxymethyllysine |
| Item Name | Carboxymethyl Lysine |
| Assay Length | 2h |
| Method | Competitive Inhibition |
| Sample Type | Serum, plasma and other biological fluids |
| Formato | 48T, <i>96T</i>, 96T×5, 96T×10, 96T×100 |
| Test Principle | This assay employs the competitive inhibition enzyme immunoassay technique. A monoclonal antibody specific to Carboxymethyl Lysine (CML) has been pre-coated onto a microplate. A competitive inhibition reaction is launched between biotin labeled Carboxymet |
| Assay procedure summary | 1. Prepare all reagents, samples and standards |
| UniProt ID | - |
Más información
CITATIONS
Advanced Glycation End Products Induce Human Corneal Epithelial Cells Apoptosis through Generation of Reactive Oxygen Species and Activation of JNK and p38 MAPK Pathways;Effects of combined lipoic acid and pyridoxine on albuminuria, advanced glycation end-products, and blood pressure in diabetic nephropathy.;Advanced glycation end-products accelerate the cardiac aging process through the receptor for advanced glycation end-products/transforming growth factor-β-Smad signaling pathway in cardiac fibroblasts;Inhibition of Advanced Glycation Endproduct Formation by Lotus Seedpod Oligomeric Procyanidins through RAGE-MAPK Signaling and NF-κB Activation in High-Fat-Diet Rats.;Association of serum N Îľ-Carboxy methyl lysine with severity of diabetic retinopathy;Hyperoside reduces albuminuria in diabetic nephropathy at the early stage through ameliorating renal damage and podocyte injury.;Increased levels of N(ε)- Carboxy methyl lysine (N(ε)-CML) are associated with topographic alterations in retinal pigment epithelium: A preliminary study;Long-term administration of advanced glycation end-product stimulates the activation of NLRP3 inflammasome and sparking the development of renal injury.;Plasma heparanase is associated with blood glucose levels but not urinary microalbumin excretion in type 2 diabetic nephropathy at the early stage ;High intake of dietary advanced glycation end-products is associated with increased arterial stiffness and inflammation in subjects with type 2 diabetes.;Antiglycation and antioxidant activities of mogroside extract from (Swingle) fruits;Elevated advanced glycation end products are associated with subfoveal ellipsoid zone disruption in diabetic macular edema;